Top Twenty Companies in The Retail Pharmaceutical Market in India, 2004

Download as doc, pdf, or txt
Download as doc, pdf, or txt
You are on page 1of 5

Top Twenty Companies in the Retail Pharmaceutical Market in India, 2004

Rank 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Company Cipla GlaxoSmithKline Ranbaxy Nicholas Piramal Sun Pharma Dr. Reddys Zydus-Cadila Aristo Pharma Abbott India Alkem Labs Aventis Lupin Micro Labs Wockhardt Torrent Novartis India Alembic Unichem Labs USV Pfizer Sector Indian MNC Indian Indian Indian Indian Indian Indian MNC Indian MNC Indian Indian Indian Indian MNC Indian Indian Indian MNC No. Of Products 707 205 437 449 350 183 330 175 87 310 44 274 461 238 150 127 169 189 86 29 Annual Sales in Rs million,2004 11,285 11,143 9190 8720 6738 4988 4959 4760 4735 4477 4367 4165 3903 3776 3747 3725 3432 3430 3390 3274 Market share (%) 2004 5.51 5.44 4.48 4.25 3.29 2.43 2.42 2.32 2.31 2.18 2.13 2.03 1.90 1.84 1.83 1.82 1.67 1.67 1.65 1.60

Rate of Growth of Top Indian Companies in the Retail Pharmaceutical Market, 1996-2004
(in Rs million and per cent)
Rank Company Annual Sales 2004 11,285 9190 8720 6738 4988 4959 4760 4477 4165 3903 3776 3747 3432 3430 3390 80,996 Market Share 2004 5.51 4.48 4.25 3.29 2.43 2.42 2.32 2.18 2.03 1.90 1.84 1.83 1.67 1.67 1.65 39.5 Annual Sales 1996 2863 2686 1363 722 557 1323 1102 926 1536 416 998 1540 1664 931 599 19,226 Market Share 1996 4.18 3.92 1.99 1.05 0.81 1.93 1.62 1.35 2.24 0.61 1.46 2.25 2.43 1.36 0.87 28.07 Annual compound rate of growth 1996-2004 18.7 16.6 26.1 32.2 31.5 18.0 20.1 21.8 13.3 32.3 18.1 11.8 9.5 17.7 24.2 19.7

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Cipla Ranbaxy Nicholas Piramal Sun Pharma Dr Reddys Zydus-Cadila Aristo Pharma Alkem Labs Lupin Micro Labs Wockhardt Torrent Alembic Unichem Labs USV Total (15 companies)

Source :ORG-MARG, retail store audit for relevant years.

References

Structural Adjustmenta Major Cause of Poverty


Author and Page information

by Anup Shah This Page Last Updated Sunday, November 28, 2010

http://www.globalissues.org/article/3/structural-adjustment-a-major-cause-of-poverty 20-09-2011

References

1. 2.

Chaudhury, S. (2005). The WTO and Indias pharmaceutical industry. Kale, D. & Athreye, S. ( 2006) Experimentation with strategy in the Indian Pharmaceutical sector.

3.

Pradhan & Prakash, J. (2006) Global competitiveness of Indian Pharmaceutical industry: Trends and Strategies.

4. 5. 6. 7. 8.

Rao, Manohar, J. (2007) , Globalization, technology and competition. Rao, Subba, S.V.R. (1997). Pharmaceutical marketing in India. Ramu, Shiva, S. (1997). Globalization-The Indian scenario. Smarta, B,R.(1997). Revitalizing the pharmaceutical business. Shahani, R. (2006). Wanted a pragmatic policy. The Hindu Survey of Indian Industry, 221-226

9.

Priolkar, S. (2009, January). Can India be pharmaceutical superpower in 2020? Pharma Times , 9-14

10.

Pecoux, O. (2009, March 23). Generics spell scale for big pharma. Businessworld. 56-57

Market shares of MNCs and Indian Companies in the Pharmaceutical Industry in India

YEAR

MNCs %

INDIAN COMPANIES %

1952 1970 1978 1980 1991 1998 2004

38 68 60 50 40 32 23

62 32 40 50 60 68 77

Source:- Chaudhuri, S. 2005 P 18

You might also like